Ophthalmic Method and Apparatus for Noninvasive Diagnosis and Quantitative Assessment of Cataract Development
20180014726 ยท 2018-01-18
Inventors
Cpc classification
International classification
Abstract
An optoelectronic apparatus and method is provided. The application of which provides a quantitative index of cataract opacity in the human eye to help the clinical practitioner screen patients for referral for cataract lens replacement surgery. The invention includes at least one adjustable intensity optical reference light source selected from the group consisting of a green light source and a red-light source. The invention also includes at least one fixed intensity cataract absorption light source, selected from the group consisting of a blue light source, an indigo light source, and a violet light source.
Claims
1. An ophthalmic apparatus for noninvasive diagnosis and quantitative assessment of cataract development, the apparatus comprising: at least one optical reference light source, wherein the at least one optical reference light source comprises an adjustable intensity light source, and wherein the at least one optical reference light source is selected from the group consisting of a green light source and a red-light source; and at least one optical test light source, wherein the at least one optical test light source comprises a predetermined intensity light source, and wherein the at least one test light source is selected from the group consisting of a blue light source, an indigo light source, and a violet light source.
2. The apparatus as in claim 1 further comprising at least one linear neutral density filter for attenuating the at least one optical reference light source.
3. The apparatus as in claim 1 further comprising at least one rotary polarization filter for attenuating the at least one reference light source.
4. The apparatus as in claim 1 further comprises: wherein the adjustable intensity light source comprises a first laser light source; and wherein the predetermined light source comprises a second laser light source.
5. The apparatus as in claim 1 further comprises: wherein the adjustable intensity light source comprises a first LED light source; and wherein the predetermined light source comprises a second LED source.
6. The apparatus as in claim 1 further comprises an index of opacity calculator and display.
7. A method for noninvasive diagnosis and quantitative assessment of cataract development, the method comprising: providing a cataract testing device; calibrating the cataract testing device, wherein calibrating the cataract testing device comprises: providing a cataract absorption light (CAL) source at a first preset intensity (CALI); providing a reference light (RL) source at a second preset intensity RLI greater than the first preset intensity; observing RLI and CALI simultaneously via a cataract free lens; and decreasing RLI in predetermined calibration steps (CS) to substantially equal CALI.
8. The method as in claim 7 wherein the CAL source is selected from the group consisting of a blue light source, an indigo light source, and a violet light source.
9. The method as in claim 7 wherein the RL source is selected from the group consisting of a green light source, and a red-light source.
10. The method as in claim 7 wherein decreasing RLI in predetermined calibration steps further comprises decreasing RLI with at least one shift in position of at least one first linear neutral density filter.
11. The method as in claim 7 wherein decreasing RLI in predetermined calibration steps further comprises decreasing RLI with at least one shift in position of at least one rotary polarization filter.
12. The method as in claim 7 further comprising: providing the reference light (RL) at the second preset intensity RLI greater than the first preset intensity; observing RLI and CALI simultaneously via a cataract lens; decreasing RLI in predetermined absorption steps (AS) to substantially equal CALI; and calculating a cataract index of opacity O=ASCS.
13. The method as in claim 12 further comprising observing the CAL within random colored dots.
14. The method as in claim 13 further comprising saving the index of opacity 0 in a medical health record.
15. A method for noninvasive diagnosis and quantitative assessment of cataract development, the method comprising: providing a cataract testing device; calibrating the cataract testing device, wherein calibrating the cataract testing device comprises: providing a cataract absorption light (CAL) source at a first preset intensity (CALI), wherein the CAL source is selected from the group consisting of a blue light source, an indigo light source, and a violet light source; providing a reference light (RL) source at a second preset intensity RLI greater than the first preset intensity, wherein the RL source is selected from the group consisting of a green light source, and a red-light source; observing RLI and CALI simultaneously via a cataract free lens; and decreasing RLI in predetermined calibration steps (CS) to substantially equal CALI, wherein decreasing RLI in predetermined calibration steps further comprises decreasing RLI with a least one filter selected from the group consisting of a linear neutral density filter and a rotary polarization filter.
16. The method as in claim 15 further comprising providing the reference light (RL) at the second preset intensity RLI greater than the first preset intensity; observing RLI and CALI simultaneously via a cataract lens; decreasing RLI in predetermined absorption steps (AS) to substantially equal CALI; calculating a cataract index of opacity O=ASCS; and saving the cataract index of opacity 0 in a medical health record
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0026] The subject matter which is regarded as the invention is particularly pointed out and distinctly claimed in the claims at the conclusion of the specification. The foregoing and other objects, features, and advantages of the invention are apparent from the following detailed description taken in conjunction with the accompanying drawings in which:
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
DETAILED DESCRIPTION
[0033] The following brief definition of terms shall apply throughout the application:
[0034] The term comprising means including but not limited to, and should be interpreted in the manner it is typically used in the patent context;
[0035] The phrases in one embodiment, according to one embodiment, and the like generally mean that the particular feature, structure, or characteristic following the phrase may be included in at least one embodiment of the present invention, and may be included in more than one embodiment of the present invention (importantly, such phrases do not necessarily refer to the same embodiment);
[0036] If the specification describes something as exemplary or an example, it should be understood that refers to a non-exclusive example; and
[0037] If the specification states a component or feature may, can, could, should, preferably, possibly, typically, optionally, for example, or might (or other such language) be included or have a characteristic, that particular component or feature is not required to be included or to have the characteristic.
[0038] Referring to
[0039] Still referring to
[0040] Step 13A and step 16 compares the GLI to the CALI. If the intensities are approximately equal then the patent test 19 is started. If the intensities are not approximately equal the GLI is decreased by one step. The resulting fractional change in transmittance of GLI is measured relative to its initial setting; that is, the extent to which the intensity of the green light is reduced in order to match the perceived intensity of the blue light. The OD or T of the corresponding filter(s) steps establishes the standard (null point) against which further changes in perceived intensity of the blue light is measured.
[0041] Still referring to
[0042] Still referring to
[0043] Still referring to
[0044] For example, using a blue CAL for one test subject, two steps (0 to 2) of the GLI filter was required to reduce the GLI to match CALI subject's healthy eye. Seven steps (0 to 7) were required to reduce the GLI to match the CALI in the cataract eye. Similarly, four steps (0 to 4) of the GLI filter were required to reduce the GLI to match a violet CALI in the subject's healthy eye, and 10 steps (0 to 10) in the cataract eye, i.e., consistent with the wave-length dependent transmissibility of light through a cataract lens.
[0045] The difference in graduated steps is denoted as an index of opacity, O, where Oblue is determined by ASC-CSC 115 using blue light CAL or Oviolet using violet light CAL. In the example, the index of opacity is Oblue is 5 (=72) and Oviolet is 6 (=104), indicating an advanced cataract. Gradations in opacity index may be any suitable gradation, limited by the gradation and range of the neutral density filter and ability of the subject to perceive light intensity differences.
[0046] In many cases the patient does not have a (control) healthy eye which serves as a within-patient standard by which the opacity of a cataract, Oblue and Oviolet, can be calculated as shown in
[0047] For example, using the prototype system shown in
[0048] Referring also to
[0049] The intensity of the light sources 23-26 is attenuated by a graduated neutral density filter 22, allowing optical density (OD) or transmittance (T) to be altered. In one embodiment, the filters 22 may be constructed of plastic (as in a plastic film strip) or glass (as in a rotating glass filtersee
[0050] Referring also to
[0051] Referring also to
[0052] The use of LEDs 37, 38 allows for versatile presentation of lights of different wavelengths. For example, LEDs of many colors can be activated and displayed in various combinations of reference light (e.g., GL) and CAL.
[0053] Referring also to
[0054] The patient or user selects 46 a reference color 42, e.g., a green light GL. The patient blocks the eye not being tested 47 and adjusts 48 intensity 42A until the intensity of the reference color 42 substantially matches 410 the intensity of the test color 41. If the reference color intensity is maximum 411 and the patient or user has not perceived the intensities of the reference color and test color as substantially equal then the patient may be tested 413 for color blindness of the reference color and selects another reference color 412.
[0055] Still referring to
[0056] It will be appreciated that an important feature of the invention discussed herein is the means (whether mechanically or electronically) to modulate the intensity of light from each light source. As discussed above, cataracts absorb blue (and to an even greater extent) violet light more than a cataract-replacement lens or a cataract-free lens, and the method relies on the subject to adjust the intensity of light from the green or red-light source to match that of the blue or violet light source. The difference in intensity (in OD units or other graduated scales) is the measure, or index, of relative opacity of the cataract compared with a clear lens.
[0057] In one test using the prototype system shown in
[0058] It will be appreciated that criteria derived from the invention discussed herein may be used for establishing a referral for CLRS. For example, in the system shown in
[0059] It should be understood that the foregoing description is only illustrative of the invention. Thus, various alternatives and modifications can be devised by those skilled in the art without departing from the invention. Accordingly, the present invention is intended to embrace all such alternatives, modifications and variances that fall within the scope of the appended claims.